BridgeMD
New treatment option for Knee Osteoarthritis
Official title Gastrocnemius Myofascial Release in Females With Knee Osteoarthritis
ClinicalTrials.gov ID: NCT07507175
What this study is testing
- What it's testing
- The goal of this clinical trial is to determine whether gastrocnemius myofascial release is effective in reducing pain and improving physical function in females with knee osteoarthritis. The main question this study aims to answer are: Does adding gastrocnemius MFR to conventional physical therapy treatment influence pain, physical function, foot posture, and knee disability compared to conventional physical therapy treatment and sham MFR in knee osteoarthritis?
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 45 to 55, women only
You may be able to join if
- Patients' ages ranged between 45 and 55 years .
- BMI ≤35
- Patients with a diagnosis of primary KOA according to the American College of Rheumatology classification at the screening visit .
- Onset of symptomatic knee osteoarthritis of ≥3 months
- Patients with grade II and III OA of the Kellgren and Lawrence system for classification of osteoarthritis .
You likely can't join if
- Patients with any previous knee surgeries or lower limb fractures.
- Chronic inflammatory diseases such as rheumatoid arthritis.
- Signs of moderately significant knee synovitis include a warm and swollen (red) knee
- History and/or physical examination findings compatible with knee internal derangement (e.g, positive Thessaly test).
- Pregnancy
- Patients who had undergone arthroscopy or treatment with intra-articular hyaluronic acid during the previous 6 months .
See the full eligibility criteria
- Patients' ages ranged between 45 and 55 years .
- BMI ≤35
- Patients with a diagnosis of primary KOA according to the American College of Rheumatology classification at the screening visit .
- Onset of symptomatic knee osteoarthritis of ≥3 months
- Patients with grade II and III OA of the Kellgren and Lawrence system for classification of osteoarthritis .
- At least one active trigger point in GM
- If both knees were diagnosed as OA, the most affected one was selected.
- Current pain intensity on the Visual Analogue Scale (VAS) ≥4/10.
- people have sufficient cognition that enables them to understand the requirements of the study, comply with the study procedures, and visit schedule.
- Diagnostic Criteria of KOA A diagnosis of knee osteoarthritis was made when knee pain is present, plus Osteophytes on radiographs, plus at least 1 of the following 3:
- Age \> 50 years
- Morning stiffness \< 30 minutes
- Crepitus on active motion
- Patients with any previous knee surgeries or lower limb fractures.
- Chronic inflammatory diseases such as rheumatoid arthritis.
- Signs of moderately significant knee synovitis include a warm and swollen (red) knee
- History and/or physical examination findings compatible with knee internal derangement (e.g, positive Thessaly test).
- Pregnancy
- Patients who had undergone arthroscopy or treatment with intra-articular hyaluronic acid during the previous 6 months .
- Use of NSAIDs one week before the screening visit .
- Orthopedic diseases, or congenital musculoskeletal deformities, or neurological disorders that may affect or interfere with the therapeutic effect.
- Participated in other intervention studies (strength training program or physiotherapy treatment for knee osteoarthritis) in the current period and the past 6 months .
- Habitual use of psychotropic or narcotic analgesics for ≥1 week within 8 weeks prior to screening .
The study team makes the final eligibility decision.
Where it's taking place
- Giza, Giza Governorate, Egypt
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 45 years to 55 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Giza, Giza Governorate, Egypt. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.